NEUROENDOCRINE (NE) TUMORS
Clinical trials for NEUROENDOCRINE (NE) TUMORS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE (NE) TUMORS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE (NE) TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New PET scan could slash radiation by 100x
Diagnosis ENROLLING_BY_INVITATIONThis study tests a new PET imaging technique that uses 10 to 100 times less radiation than standard scans. Researchers will inject 200 healthy volunteers and patients with a radioactive tracer and use a high-sensitivity scanner to see if image quality remains good enough for dete…
Matched conditions: NEUROENDOCRINE (NE) TUMORS
Phase: PHASE2 • Sponsor: Akiva Mintz • Aim: Diagnosis
Last updated Jun 23, 2026 12:00 UTC
-
New imaging agent aims to light up Hard-to-Find cancers
Diagnosis TerminatedThis pilot trial aimed to test whether a new radioactive imaging agent, 111In-ABD147, could help detect metastatic solid tumors using SPECT/CT scans. The agent targets a protein called DLL3 found on many cancer cells. The study was withdrawn before any participants were enrolled,…
Matched conditions: NEUROENDOCRINE (NE) TUMORS
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 23, 2026 11:59 UTC